Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
The Global Remdesivir Market Report by The Business Research Company covers remdesivir market drivers and restraints, remdesivir market size, major players, and the impact of COVID-19 on the remdesivir market.
The remdesivir market consists of sales of remdesivir drugs currently found effective in treating the COVID-19 disease. Remdesivir (RDV) is one of the promising drugs used currently for the treatment of the COVID-19 disease. Gilead, the US drug manufacturer is expanding its Remdesivir production due to the high demand for this drug. RDV is a synthetic compound throughout the class of antiviral drugs that target RNA synthesis.
Increasing prevalence of COVID-19 disease globally is a key factor driving the growth of the remdesivir market.
The global remdesivir market is expected to grow from $1.98 billion in 2020 to $2.55 billion in 2021 at a compound annual growth rate (CAGR) of 28.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.89 billion in 2025 at a CAGR of 28%.
Request A Sample For The Global Remdesivir Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp
Some remdesivir market trends include the licensing for generic versions of the drug. Gilead licensed remdesivir for COVID-19 to companies manufacturing generic drugs for sale in 127 countries. Five generic companies Cipla, Ferozsons Labs, Hetero Labs, Jubilant Lifesciences and Mylan will have the right to manufacture and sell generic versions of the drug in mostly lower-income countries, as well as higher-income countries that face significant obstacles to healthcare access.
Global remdesivir market segments include:
1) By Route Of Administration: Oral, Intravenous.
2) By Dosage Form: Tablets, Frozen Solution, Lypholized Solution.
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Remdesivir Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
The Remdesivir Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides remdesivir market overviews, analyzes and forecasts market size, share, remdesivir market players, remdesivir market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The remdesivir market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Remdesivir Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, Dr Reddy’s Laboratories, Inovio Pharmaceuticals, Borui Bio-Pharmaceutical, Berry Global Group, Others.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The remdesivir Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The remdesivir Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Remdesivir Global Market Report 2021:
Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030
Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
